Value Assessment Gives Us Estimates – but Is It Answering the Right Questions?

Author(s)

Moderator: Samuel Robert Nussbaum, MD, Innovation and Value Initiative, Clayton, MO, USA
Panelists: Steven Pearson, MD, MSc, Institute for Clinical and Economic Review, Boston, MA, USA; Annie Kennedy, BS, EveryLife Foundation for Rare Diseases, Washington, DC, USA; Bruce W Sherman, MD, FCCP, FACOEM, North Carolina Business Group on Health, Greensboro, NC, USA

ISSUE: In the US, value assessment is rapidly becoming a cornerstone of decision making within contracting and payment negotiation, even as debate continues about whether we have the right tools and methods to support the increasing demand for quantifiable estimates of value. These value assessments give us numbers – but are they answering all of the right questions? And if not, what additional elements and frameworks are needed?

OVERVIEW: This panel will explore the current capabilities and limitations of value assessment methods, consider the most important unmet needs in discerning high and low-value care, and debate the best way forward to answering questions that matter to all stakeholders. Samuel Nussbaum will moderate and provide insight on payers’ needs when making value-driven decisions. Steven Pearson will provide the value assessor’s perspective and describe current real-world use. Annie Kennedy will provide the patient community perspective on the alignment between value assessments and value delivered to patients. Bruce Sherman will provide insights from the perspective of the employer community. Panelists will provide brief remarks, reserving the majority of the session for panel discussion and audience questions.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Topic

Health Technology Assessment

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×